181 related articles for article (PubMed ID: 35005644)
21. Multiplexed CRISPR-Cas9 protocol for large transgene integration into the Schistosoma mansoni genome.
Ittiprasert W; Moescheid MM; Mann VH; Brindley PJ
STAR Protoc; 2024 Mar; 5(1):102886. PubMed ID: 38354082
[TBL] [Abstract][Full Text] [Related]
22. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
[TBL] [Abstract][Full Text] [Related]
23. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
24. A protocol for efficient CRISPR-Cas9-mediated knock-in in colorectal cancer patient-derived organoids.
Okamoto T; Natsume Y; Yamanaka H; Fukuda M; Yao R
STAR Protoc; 2021 Dec; 2(4):100780. PubMed ID: 34585151
[TBL] [Abstract][Full Text] [Related]
25. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
[TBL] [Abstract][Full Text] [Related]
26. Genome editing in
Sinha T; Yazdani SS
STAR Protoc; 2022 Sep; 3(3):101629. PubMed ID: 36042883
[TBL] [Abstract][Full Text] [Related]
27. Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a.
Ling X; Chang L; Chen H; Liu T
STAR Protoc; 2022 Jun; 3(2):101321. PubMed ID: 35496795
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9-Based Genome Editing and Cytidine Base Editing in
Wang Y; Wang Z; Ji Q
STAR Protoc; 2020 Jun; 1(1):100025. PubMed ID: 33111078
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9-mediated insertion of a short artificial intron for the generation of conditional alleles in mice.
Cassidy A; Pelletier S
STAR Protoc; 2023 Mar; 4(1):102116. PubMed ID: 36853660
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
31. Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.
Rathbone T; Ates I; Fernando L; Addlestone E; Lee CM; Richards VP; Cottle RN
CRISPR J; 2022 Jun; 5(3):397-409. PubMed ID: 35238624
[TBL] [Abstract][Full Text] [Related]
32. Protocol for precision editing of endogenous Chlamydomonas reinhardtii genes with CRISPR-Cas.
Nievergelt AP; Diener DR; Bogdanova A; Brown T; Pigino G
STAR Protoc; 2024 Mar; 5(1):102774. PubMed ID: 38096061
[TBL] [Abstract][Full Text] [Related]
33. CRISPR-Cas9-Mediated Genome Editing in the Filamentous Ascomycete Huntiella omanensis.
Wilson AM; Wingfield BD
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32597846
[TBL] [Abstract][Full Text] [Related]
34. Protocol for Efficient CRISPR/Cas9/AAV-Mediated Homologous Recombination in Mouse Hematopoietic Stem and Progenitor Cells.
Tran NT; Trombke J; Rajewsky K; Chu VT
STAR Protoc; 2020 Jun; 1(1):100028. PubMed ID: 32685932
[TBL] [Abstract][Full Text] [Related]
35. Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a.
Ishibashi R; Maki R; Toyoshima F
Sci Rep; 2024 Mar; 14(1):7615. PubMed ID: 38556532
[TBL] [Abstract][Full Text] [Related]
36. Screening of CRISPR-Cas9-generated point mutant mice using MiSeq and locked nucleic acid probe PCR.
Vasu K; Fox PL
STAR Protoc; 2021 Dec; 2(4):100785. PubMed ID: 34585153
[TBL] [Abstract][Full Text] [Related]
37. Generation of mouse models carrying B cell restricted single or multiplexed loss-of-function mutations through CRISPR-Cas9 gene editing.
Ten Hacken E; Gruber M; Hernández-Sánchez M; Hoffmann GB; Baranowski K; Redd RA; Clement K; Livak K; Wu CJ
STAR Protoc; 2023 Dec; 4(4):102165. PubMed ID: 37729058
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-Cas9 strategies to insert MS2 stem-loops into endogenous loci in
Hoppe C; Ashe HL
STAR Protoc; 2021 Mar; 2(1):100380. PubMed ID: 33786461
[TBL] [Abstract][Full Text] [Related]
39. Targeting endogenous proteins for spatial and temporal knockdown using auxin-inducible degron in Caenorhabditis elegans.
Kurashina M; Mizumoto K
STAR Protoc; 2023 Mar; 4(1):102028. PubMed ID: 36640369
[TBL] [Abstract][Full Text] [Related]
40. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
